The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...

The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...

For years nasal sprays have helped people with allergies. Recently, treating migraines, depression and opioid overdoses joined the list. There’s even an intranasal option for the flu vaccine. Doctors ...

The FDA stated in a release that, "The most commonly reported side-effects of FluMist are fever over 100°F in children 2 ...

The Lockheed L-1011 'TriStar' was one of the defining aircraft of the early widebody era and the third twin-aisle jet to ...

The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...

In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.

· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...

FluMist is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a ...

The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...